Astellas Pharma Inc (ALPMY)

15.29 +0.12  +0.79% OTC Markets Apr 22, 15:53 USD
View Full Chart
Price Chart
View All ALPMY News


View All Events


Date Type Description
09/28/2020 Dividends 0.2011 Normal, declared September 28, 2020 and paid December 15, 2020
View All Performance Charts

Total Returns Comparison

Ratings & Reports



  • Description: Astellas Pharma Inc is a drug manufacturing company that sells pharmaceutical products across the globe. The vast majority of the company's revenue is derived from Japanese markets, followed by the Americas. Royalty income makes up a small percentage of Astellas' overall sales. Its largest therapeutic area by sales composition is oncology, followed by urology and transplantation. The company uses mergers and acquisitions as part of its long-term growth strategy. Astellas enters into strategic partnerships and licensing agreements to strengthen its commercialization platforms.
  • URL:
  • Investor Relations URL: N/A
  • HQ State/Province: N/A
  • Sector: Healthcare
  • Industry: Drug Manufacturers - General
  • Equity Style: Large Cap/Value
  • Next Earnings Release: N/A
  • Last Earnings Release: N/A
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: Sep. 28, 2020

Top Fund Holders

Symbol Name Weighting
F000015T8G FT Pharmaceutical Select 42 F RE 4.00%
FIZOMX FT Pharmaceutical Select 43 RE 3.81%
F000015G78 FT Pharmaceutical Select 41 CA 3.67%
FKUZFX FT Pharmaceutical Select 40 RE 3.43%
F000015KOD FT Strategic International Opp 14 F CA 1.60%





Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.